Celcuity Inc. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Description of Registered Securities (Filed With SEC on October 9, 2024)
- Form of Non-Qualified Stock Option Transfer Agreement pursuant to Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan (Filed With SEC on May 15, 2024)
- Amendment to Form of Stock Option Agreement pursuant to Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan (Filed With SEC on May 15, 2024)
- Form of Amendment to Placement Agents Warrants, dated February 13, 2024 (Filed With SEC on May 15, 2024)
- Form of Amendment to Warrants to Purchase Shares of Common Stock, dated February 13, 2024 (Filed With SEC on May 15, 2024)
- Second Amendment to Loan and Security Agreement, dated March 29, 2024 by and among the Company and Innovatus Life Sciences Lending Fund I, L.P (Filed With SEC on March 29, 2024)
- Description of Registered Securities (Filed With SEC on March 27, 2024)
- Certificate of Designations (Filed With SEC on May 18, 2022)
- Open Market Sale AgreementSM, dated February 4, 2022, by and between Celcuity Inc., and Jefferies LLC (Filed With SEC on February 4, 2022)
- Equity Grant Agreement, dated April 8, 2021 between the Company and Pfizer, Inc (Filed With SEC on April 8, 2021)
- Clinical Trial Agreement, Amendment No. 1, between NSABP Foundation, Inc and Celcuity Inc., dated October 15, 2020 (Filed With SEC on February 16, 2021)
- Description of Registered Securities (Filed With SEC on March 13, 2020)
- Form of Plan of Conversion (Filed With SEC on September 12, 2017)
- ClinicalTrial Agreement FB-12Phase II Study Between NSABPFoundation, Inc. and Celcuity,LLC (Filed With SEC on August 23, 2017)
- CELCUITYLLC 2012 EQUITY INCENTIVEPLAN UNIT OPTION AGREEMENT (Filed With SEC on August 23, 2017)
- CELCUITY LLC 2012 EquityIncentive Plan Adopted August 10, 2012 (Filed With SEC on August 23, 2017)
